MARIANNE BOWMAN: Open Payments
NPI 1790268977 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 24 payments from 11 companies in 2025. Trend: 2023 $1,020 · 2024 $703 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $177 |
| ABBVIE INC. | 5 | $130 |
| Amgen Inc. | 2 | $51 |
| Astellas Pharma US Inc | 2 | $42 |
| PFIZER INC. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: Ozempic, QULIPTA, ELIQUIS, OTEZLA, UBRELVY, Veozah, Cologuard Collection Kit, KISUNLA.
Industry payments across VA — which companies pay providers there.
